Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elizabeth M. Guettler
Observed name:
Elizabeth Guettler
Institutions:
Lady Davis Institute for Medical Research,
McGill University
Observed institutions:
Jewish General Hospital,
Lady Davis Institute for Medical Research,
University of Manitoba,
McGill University
ORCID:
0000-0002-0176-9407
Observed ORCID:
0000-0002-0176-9407
OpenAlex ID:
A5060287320
Exceptional Nuclease Resistance of DNA and RNA with the Addition of Small-Molecule Nucleobase Mimics
2024
·
Christophe Lachance-Brais
, Chihyu Yao
, et al.
·
Journal of the American Chemical Society
·
26
Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2022
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
·
Molecular Cancer Therapeutics
·
11
PDF
mTOR inhibition enhances the antitumor efficacy of pan-RAF-MEK blockade by inhibiting the ATF4-MTHFD2 pathway
2026
·
Feiyang Cai
, Fan Huang
, et al.
·
Cell Death and Disease
·
1
PDF
RAB1A is a novel vulnerability in uveal melanoma revealed by dual inhibition of MNK1/2 and mTOR
2026
·
Raúl E. Flores-González
, Christophe Goncalves
, et al.
·
Cell Death and Differentiation
·
1
PDF
Combined Inhibition of MNK Signaling and BET Proteins Reveals TGM2 as a Novel Vulnerability in Melanoma
2024
·
Antoine Méant
, Omar Moussa
, et al.
·
Journal of Investigative Dermatology
·
1
PDF
Supplementary Data from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2025
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
Supplementary Figure 2 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2025
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
PDF
Supplementary Figure 1 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2025
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
PDF
Supplementary Figure 3 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2025
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
PDF
Supplementary Methods and Tables from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2025
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
Supplementary Figure 1 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
PDF
Supplementary Data from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
Data from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
Supplementary Figure 3 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
Supplementary Methods and Tables from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
Data from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
Supplementary Data from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
Supplementary Figure 2 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
Supplementary Figure 2 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
PDF
Supplementary Figure 3 from Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer
2023
·
Sathyen A. Prabhu
, Omar Moussa
, et al.
PDF
Show more works
View as search
Works count:
20
Citation count:
40
H-index:
2
I10-index:
2
Year
Topic
Type